Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 

Update Notes


MEPS HC-010A: 1996 Prescribed Medicines File


Update #8: 2/02/18

A problem was discovered with the linking between the MEPS Prescribed Medicines files and the Cerner Multum file that resulted in some incorrect therapeutic classes being assigned. The Multum Lexicon Addendum files (HC-068) contain the corrected therapeutic classes. Analysts should use caution when using the Cerner Multum therapeutic class variables for analysis and should always check for accuracy, because the Multum classification has been changed by the addition of new classes and subclasses, and by changes in the hierarchy of classes. See the documentation for the Multum Lexicon Addendum files for examples.

The Multum Lexicon Addendum files (HC-068) also contain an additional variable not in the 1996 through 2012 MEPS Prescribed Medicines files: the generic name of the drug most commonly used by prescribing physicians.


Update #7: 11/22/13

STATA Programming Statements have been added.


Update #6: 06/28/12

A problem was discovered with the linking between the MEPS Prescribed Medicines files and the Cerner Multum file that resulted in some incorrect therapeutic classes being assigned. In particular, some diagnostic tests and medical devices were inadvertently assigned to be in a therapeutic class when they should not have been. Specifically, from 1996-2002, some diabetic supplies were assigned to be in TC1S1=101 (sex hormone), and from 2003 through 2010 some diabetic supplies were assigned to be in TC1S1=37 (toxiods). In addition, starting in 2006, NDC 00169750111 should have been assigned to TC1=358 and TC1S1=99. Analysts should use caution when using the Cerner Multum therapeutic class variables for analysis and should always check for accuracy, because there may be additional problems not described in this user note.


Update #5: 10/26/12

SPSS Programming Statements have been added.


Update #4: 06/06/01

For approximately 9,000 records on the Prescribed Medicines File (HC-010A), health conditions were imputed based upon the type of medication reported. Therefore, condition data included on these records will not necessarily match the conditions identified on the 1996 Condition File (HC-006R) for these respondents.

Because these prescribed medicine records were imputed, they cannot be linked to the Condition File using the Condition Link File (File 1 of HC-010I). These records can be identified on the Prescribed Medicines File where PCIMPFLG=0. This problem will not exist for the 1997 Prescribed Medicines File.


Update #3: 3/16/01

This release updates data previously released on the 1996 Prescribed Medicines File(HC-010A), Differences between this release and the earlier release are the following:

1) MEPS staff discovered an inaccuracy in the number of times a household reported purchasing or otherwise obtaining a prescription drug in a particular round for a small percentage of household-reported medications in the Spring 2000 release. This inaccuracy was due to an instrument design flaw which caused interviewer error, and in isolated cases, resulted in mis-reported large numbers of prescription refills for a medicine in a given round. For some cases, it seems that the year that the person started taking the drug was recorded in the field that gives the number of times that the person purchased, or otherwise obtained the drug, during the round, as well as in the field that provides the year the person started taking the medicine. For example in the round a drug was first mentioned, when a person reported having first started taking the drug in 1996, a "96" was entered in the field for the year the person first started taking the drug. For the problem cases, a "96" also appeared in the preceding field indicating the number of times the drug was reported as being purchased or otherwise obtained during the round. Outlier values where this situation (and similar instances) occurred were determined by comparing the number of days a respondent was in the round and the number times the person reported having purchased or otherwise obtained the drug in the round, and were determined in consultation with an industry expert. For the cases where this error occurred, a new value for the number of times a person reported purchasing or otherwise obtaining the drug for that round was imputed.

2) In the Spring 2000 release, the prescribed medicine events in which a household respondent did not know/remember the number of times a certain prescribed medicine was purchased or otherwise obtained in a particular round were inadvertently excluded from the file. For those events, all the data related to that drug event, including the number of times a respondent purchased or otherwise obtained the drug in a particular round, was imputed from a donor drug event with similar characteristics.

3) Based on the two issues described above, as well as additional editing rules, the variable that contains the number of times a prescription was purchased or otherwise obtained by a person in a round was edited. Round 3 drugs, which spanned 1996 and 1997, had to be reallocated between 1996 and 1997. Because of this reallocation of Round 3 events, it is possible that records (and persons) included on the Spring 2000 release may not be included on this release.

4) This release DOES include the variable SAMPLE and DOES NOT include the variable FREEFLG. The SAMPLE variable indicates if a respondent reported receiving a free sample of a prescription medicine in the round (0=no, 1=yes). Therefore, SAMPLE=1 for all acquisitions of a certain prescription medicine for a person during a round that the respondent reported having received a free sample of that prescription during the round. In the Spring 2000 release, FREEFLG (which is NOT included on this release) indicated if a record on the file had been designated as a free sample. After reviewing the data and questionnaire in great detail, it was determined that it was not appropriate to make this assumption.

5) Some of the estimation examples (see Section 4 of documentation) had to be revised because the variable FREEFLG is not included on this release. (Please see #4 above for details.) The variable DIABFLG was substituted for the variable FREEFLG in the estimation examples, as necessary.


Update #2: 8/01/00

An updated version of File 1 of the 1996 Prescribed Medicines File (HC-010A) was released on 8/1/00. This file is identical to the previous version with the exception of the condition variables (NUMCOND, evICDiX, evPROiX and evCCCiX), which were modified for a subset of records. At the present time users can obtain the correct set of linked condition variables for this file by using the updated condition-event link file provided as File 1 of the Appendix File, HC-010I, with the condition file, HC-006. See the HC-010I documentation for information on linking event files to the condition file.


Update #1: 4/28/00

Public data users should note the following changes to the 1996 Prescribed Medicines File (HC-010A) since the preliminary release of this file in December 1999 are:

1. Prescribed medicines event identifiers are now unique for all purchases as well as other types of acquisitions including free samples.

2. RXBEGYR (formerly RXBEGYY) and RXBEGMM have been recoded and will differ slightly from the preliminary release.

3. Condition and clinical classification codes have been ordered so that up to three valid codes are listed for each prescribed medicine event. Valid condition codes are followed by invalid codes, when appropriate.

4. Detailed linking examples, including SAS code, are included in the forthcoming Appendix File (May 2000) which will enable analysts to perform various linking activities including prescribed medicines to conditions (and vice-versa) and prescribed medicines to other events (and vice-versa).


MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov